Find Tc-99M Tetrofosmin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Technetium tc-99m tetrofosmin, Q7692231
Molecular Formula
C18H40O4P2Tc
Molecular Weight
479.4  g/mol
InChI Key
BDMZPZIFZPWFFW-UHFFFAOYSA-N

Tc-99M Tetrofosmin
Technetium Tc-99m Tetrofosmin is a radiopharmaceutical consisting of tetrofosmin, composed of two bidentate diphosphine ligands chelating the metastable radioisotope technetium Tc-99 (99mTc), with potential imaging activity upon SPECT (single photon emission computed tomography). Upon administration, technetium Tc 99m tetrofosmin is preferentially taken up by, and accumulates in, myocardial cells. Upon imaging, myocardial cells can be visualized and changes in ischemia and/or perfusion can be detected.
1 2D Structure

Tc-99M Tetrofosmin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[bis(2-ethoxyethyl)phosphanyl]ethyl-bis(2-ethoxyethyl)phosphane;technetium
2.1.2 InChI
InChI=1S/C18H40O4P2.Tc/c1-5-19-9-13-23(14-10-20-6-2)17-18-24(15-11-21-7-3)16-12-22-8-4;/h5-18H2,1-4H3;
2.1.3 InChI Key
BDMZPZIFZPWFFW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCOCCP(CCOCC)CCP(CCOCC)CCOCC.[Tc]
2.2 Synonyms
2.2.1 MeSH Synonyms

1. 99mtc-tetrafosmin

2. 99mtc-tetrofosmin

3. Myoview

4. Ppn-1011

5. Ppn1011

6. Tc-99m-ppn1011

7. Tc-99m-tetrofosmin

8. Technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane

9. Technetium Tc-99m Tetrofosmin

10. Technetium(1+)-99tc, Bis(6,9-bis(2-ethoxyethyl)-3,12-dioxa-6,9-diphosphatetradecane-.kappa.p,.kappa.p')dioxo-, (oc-6-11)-

11. Technetium-99m-tetrofosmin

2.2.2 Depositor-Supplied Synonyms

1. Technetium Tc-99m Tetrofosmin

2. Q7692231

2.3 Create Date
2014-03-06
3 Chemical and Physical Properties
Molecular Weight 479.4 g/mol
Molecular Formula C18H40O4P2Tc
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count19
Exact Mass479.14654 g/mol
Monoisotopic Mass479.14654 g/mol
Topological Polar Surface Area36.9 Ų
Heavy Atom Count25
Formal Charge0
Complexity201
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Radiopharmaceuticals

Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)


Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty